Find Triflusal manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 322-79-2, 2-acetoxy-4-trifluoromethylbenzoic acid, Disgren, 2-acetoxy-4-(trifluoromethyl)benzoic acid, 2-acetyloxy-4-(trifluoromethyl)benzoic acid, Triflusal [inn]
Molecular Formula
C10H7F3O4
Molecular Weight
248.15  g/mol
InChI Key
RMWVZGDJPAKBDE-UHFFFAOYSA-N
FDA UNII
1Z0YFI05OO

Triflusal
Triflusal is a 2-acetoxy-4-trifluoromethylbenzoic acid and it is an aspirin chemically-related molecule but not a derivative. The benefits of this agent are the lack of action over the arachidonic acid pathway, the driven production of nitric oxide and the increase of cyclic nucleotide concentration on endothelial cells. The latest translates into the expansion of peripheral blood vessels. It is very important as a secondary prevention of ischemic stroke by offering a lower risk of bleeding. It was developed by J. Uriach and Company and even though it is commercialized in different countries it is not approved by the FDA, EMA or HealthCanada.
1 2D Structure

Triflusal

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-acetyloxy-4-(trifluoromethyl)benzoic acid
2.1.2 InChI
InChI=1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16)
2.1.3 InChI Key
RMWVZGDJPAKBDE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
1Z0YFI05OO
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-acetoxy-4-trifluoromethylbenzoic Acid

2. Disgren

2.3.2 Depositor-Supplied Synonyms

1. 322-79-2

2. 2-acetoxy-4-trifluoromethylbenzoic Acid

3. Disgren

4. 2-acetoxy-4-(trifluoromethyl)benzoic Acid

5. 2-acetyloxy-4-(trifluoromethyl)benzoic Acid

6. Triflusal [inn]

7. 2-(acetyloxy)-4-(trifluoromethyl)benzoic Acid

8. Benzoic Acid, 2-(acetyloxy)-4-(trifluoromethyl)-

9. 1z0yfi05oo

10. Triflusal (inn)

11. Ncgc00016431-01

12. 2-acetoxy-4-trifluoromethyl-benzoic Acid

13. Cas-322-79-2

14. Triflusalum

15. Grendis

16. Aflen

17. Triflusalum [inn-latin]

18. Ur 1501

19. Drisgen

20. Triflusal [inn:ban]

21. Einecs 206-297-5

22. Unii-1z0yfi05oo

23. 4-trifluoromethylsalicylic Acid Acetate

24. Brn 2945374

25. Tecnosal

26. Triflux

27. Alpha,alpha,alpha-trifluoro-2,4-cresotic Acid Acetate

28. Prestwick_851

29. Alpha,alpha,alpha-trifluoro-2,4-creosotic Acid Acetate

30. Triflusal [mi]

31. Prestwick0_000528

32. Prestwick1_000528

33. Prestwick2_000528

34. Prestwick3_000528

35. Triflusal [mart.]

36. Triflusal [who-dd]

37. Dsstox_cid_25305

38. Dsstox_rid_80791

39. Dsstox_gsid_45305

40. Bspbio_000515

41. 4-10-00-00619 (beilstein Handbook Reference)

42. Schembl136423

43. 3-acetoxy-alpha,alpha,alpha-trifluoro-p-toluic Acid

44. Spbio_002436

45. Bpbio1_000567

46. Zinc2220

47. Chembl1332032

48. Dtxsid8045305

49. Triflusal [ep Monograph]

50. Chebi:94721

51. 2,4-cresotic Acid, Alpha,alpha,alpha-trifluoro-, Acetate

52. Hms1569j17

53. Hms2096j17

54. Hms3652m11

55. Hms3713j17

56. Hms3885i13

57. Bcp10024

58. Hy-b0531

59. Tox21_110436

60. Mfcd00866793

61. S3200

62. Ur1501

63. Akos015890393

64. Ac-1829

65. Ccg-220528

66. Ccg-222319

67. Db08814

68. Mb01536

69. Ur-1501

70. 2-acetoxy-4-trifluoromethyl Benzoic Acid

71. Acetyl-4-(trifluoromethyl)salicylic Acid

72. Ncgc00016431-02

73. Ncgc00016431-04

74. Ncgc00016431-11

75. As-63983

76. A5797

77. B1461

78. Ft-0601555

79. Sw196982-3

80. T3601

81. D07142

82. T72290

83. 322t792

84. Sr-01000872666

85. Q1758668

86. Sr-01000872666-1

87. W-106849

88. Brd-k71696703-001-01-2

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 248.15 g/mol
Molecular Formula C10H7F3O4
XLogP32.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count3
Exact Mass248.02964319 g/mol
Monoisotopic Mass248.02964319 g/mol
Topological Polar Surface Area63.6 Ų
Heavy Atom Count17
Formal Charge0
Complexity313
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Triflusal is indicated as prophylaxis of thromboembolic disorders. It has been registered in Spain and in other countries of Europe, South America and South Korea for the prevention of Stroke and myocardial infarction.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Triflusal is an antithrombotic anticoagulant. It irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1. Triflusal affects many other targets such as NF kappa B, which is a gene expression regulatory factor for cycloxygenase-a and cytokines. Numerous studies comparing the efficacy and safety profile (i.e. systemic hemorrhage) between triflusal and acetylsalsylic acid has shown either no significant difference or a better effacy and safety profile for triflusal. Triflusal has been shown to protect cerebral tissue due to its inhibition of lipid peroxidation resulting from anoxia-reoxygenation.


5.2 MeSH Pharmacological Classification

Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)


5.3 ATC Code

B - Blood and blood forming organs

B01 - Antithrombotic agents

B01A - Antithrombotic agents

B01AC - Platelet aggregation inhibitors excl. heparin

B01AC18 - Triflusal


5.4 Absorption, Distribution and Excretion

Absorption

Absorbed in the small intestine with a bioavailability range from 83% to 100%. There is no significant difference between the absorption of the oral solution and capsule formulation. Triflusal displays a Cmax of 11.6 mcg/ml and a tmax of 0.88 h. The major metabolite of triflusal presents different pharmacokinetic properties by showing a Cmax and tmax of 92.7 mcg/ml and 4.96 h, respectively.


Route of Elimination

The elimination pathway of triflusal is primarily renal. Urine analysis has shown the presence of unchanged triflusal, HTB and the glycine conjugate of HTB.


Volume of Distribution

The reported volume of distribution for triflusal is of 34L.


Clearance

Renal clearance is 0.8 +/- 0.2L/h and 0.18 +/1 0.04L/h for triflusal and HTB, respectively.


5.5 Metabolism/Metabolites

In the liver, triflusal undergoes deacetylation, forming its main metabolite 2-OH-4-trifluoromethyl benzoic acid (HTB). This major metabolite seems to have marked antiplatelet properties in vitro.


5.6 Biological Half-Life

In the healthy human, the half-life is 0.5 +/- 0.1h, while that of HTB is 34.3 +/- 5.3h.


5.7 Mechanism of Action

Triflusal is chemically related to acetylsalicylic acid (ASA) and irreversibly inhibits cycloxygenase-1 (COX-1) in platelets. Acetylation of the active group of COX-1 prevents the formation of thromboxane-B2 in platelets. However, it is unique because it spares the arachidonic acid metabolic pathway in endothelial cells. In addition, it favors the production of nitric oxide, a vasodilator.


Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Triflusal Manufacturers

A Triflusal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triflusal, including repackagers and relabelers. The FDA regulates Triflusal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triflusal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Triflusal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Triflusal Suppliers

A Triflusal supplier is an individual or a company that provides Triflusal active pharmaceutical ingredient (API) or Triflusal finished formulations upon request. The Triflusal suppliers may include Triflusal API manufacturers, exporters, distributors and traders.

click here to find a list of Triflusal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Triflusal KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Triflusal Drug Master File in Korea (Triflusal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Triflusal. The MFDS reviews the Triflusal KDMF as part of the drug registration process and uses the information provided in the Triflusal KDMF to evaluate the safety and efficacy of the drug.

After submitting a Triflusal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Triflusal API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Triflusal suppliers with KDMF on PharmaCompass.

Triflusal CEP

A Triflusal CEP of the European Pharmacopoeia monograph is often referred to as a Triflusal Certificate of Suitability (COS). The purpose of a Triflusal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Triflusal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Triflusal to their clients by showing that a Triflusal CEP has been issued for it. The manufacturer submits a Triflusal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Triflusal CEP holder for the record. Additionally, the data presented in the Triflusal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Triflusal DMF.

A Triflusal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Triflusal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Triflusal suppliers with CEP (COS) on PharmaCompass.

Triflusal GMP

Triflusal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Triflusal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triflusal GMP manufacturer or Triflusal GMP API supplier for your needs.

Triflusal CoA

A Triflusal CoA (Certificate of Analysis) is a formal document that attests to Triflusal's compliance with Triflusal specifications and serves as a tool for batch-level quality control.

Triflusal CoA mostly includes findings from lab analyses of a specific batch. For each Triflusal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Triflusal may be tested according to a variety of international standards, such as European Pharmacopoeia (Triflusal EP), Triflusal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triflusal USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty